Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Elekta AB

www.elekta.com

Latest From HanAll Pharmaceutical Co. Ltd.

Korean Pharma Spawns US Cancer Biotech Startup

Dr. Benjamin R Cowen, COO of ImmunoMet Therapeutics, reveals how the Houston-based startup is developing OXPHOS inhibitors to treat drug resistant and relapse cancers.

Companies StartUps and SMEs

So What’s Next For Hanmi?

Hanmi's surprising success in R&D this year has left people wondering what strategy the leading South Korean pharma firm may take next to transform into a big global player like Takeda. With an expected massive inflow of cash from a series of big licensing out deals with multinationals, it may be poised to change its R&D strategy and even engage in some M&A.

BioPharmaceutical South Korea

Bioneer Deal May Point To Yuhan R&D Strategy Change

Yuhan has been seen as one of the less aggressive South Korean pharma firms in terms of beefing up R&D. But now, the company may be shifting its strategy as it has decided to become the second biggest shareholder of local bioventure Bioneer, in a move to strengthen its pipeline including immuno-oncology drugs and to diversify into new businesses.

BioPharmaceutical South Korea

Planned Daewoong-HanAll Merger Hit By Union Protests

The planned acquisition of South Korea’s HanAll Biopharma by its bigger rival Daewoong Pharmaceutical has met a setback as unionized workers are HanAll protesting the plan, demanding compensation and job security amid concerns over the transaction.

BioPharmaceutical South Korea
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register